The Latest Cardiac and Vascular News
ALBANY, New York, March 8, 2018 /PRNewswire/ — The global Cardiac Resynchronization Therapy Systems market was valued at approximately US$ 3.1 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 5.3% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Cardiac Resynchronization […]
LONDON–(BUSINESS WIRE)– LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) today announced that it has entered into a definitive Stock and Asset Purchase Agreement (“Purchase Agreement”) to divest its Cardiac Rhythm Management business franchise to MicroPort Scientific Corporation (“MicroPort”). LivaNova and MicroPort executed and delivered the Purchase Agreement, pursuant to the terms of a binding Letter of Intent, […]
REDWOOD CITY, Calif., March 02, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced it has regained compliance with Nasdaq listing requirements. In a letter dated March 1, 2018, Nasdaq informed the Company that it has achieved compliance with […]
NEWARK, Del.–(BUSINESS WIRE)–W. L. Gore & Associates today announced that Jason Field, global sales and marketing leader for Gore Medical Products Division, will succeed Terri Kelly in the role of President and CEO effective April 1, 2018. Terri Kelly will continue to serve on Gore’s Board of Directors through July 2018. […]
DUBLIN–(BUSINESS WIRE)–The “Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) – Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering. The Global Embolic Protection Devices Market is Projected to Reach USD 604.9 Million By 2023 from USD […]
GALWAY, Ireland–(BUSINESS WIRE)– 4Tech Inc., a leader in the field of transcatheter tricuspid valve repair, announces changes in its leadership team: Tom Fleming will join the company as President and Chief Executive Officer (CEO), effective as of March 2018; and Keith D. Dawkins, M.D., has joined as Chief Medical Officer (CMO), effective immediately. Tom […]
New Vascular Closure Device for Multi-Access Mid-Bore Vein Procedures, Specifically Cardiac Ablation, Aims to Reduce Time to Ambulation and Improve the Patient Experience SANTA CLARA, Calif.–(BUSINESS WIRE)– Cardiva Medical ®, an innovator in the field of vascular closure, today announced that the company has closed on $11 million in additional financing – […]
Mitralign raises $10m FEBRUARY 21, 2018 BY BRAD PERRIELLO, MassDevice Mitralign, which is looking to commercialize its namesake mitral valve treatment and pursue regulatory nods for its Trialign tricuspid valve device, said it raised nearly $10 million. The $9.8 million funding, of a hoped-for $30.2 million, came from 19 unnamed investors beginning […]
IRVINE, California and DENVER, Colorado, February 13, 2018 – McDermott & Bull announced today the acquisition of Denver-based Prime-Core Executive Search and the addition of Ken Dropiewski as Principal Consultant. Dropiewski will join the firm’s Life Sciences Group, specializing in the Med-Tech space. “The addition of Ken to our firm is a huge […]
Secured Lenders Convert $38 Million of Debt into Equity REDWOOD CITY, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) — Avinger, Inc.(NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the pricing of an underwritten public offering of Series B convertible preferred stock, together with warrants, for gross […]
